Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study

Jeong Hoon Lee,Ji Yong Ahn,Kee Don Choi,Hwoon‐Yong Jung,Jung Mogg Kim,Gwang Ho Baik,Byung‐Wook Kim,Jun Chul Park,Hye‐Kyung Jung,Soo Jeong Cho,Cheol Min Shin,Yoon Jin Choi,Si Hyung Lee,Ji Hyun Kim,Wan Sik Lee,Jae Kyu Sung,Jun‐Won Chung,Dae Young Cheung,Hyuk Lee,Yang Won Min,Jae J. Kim,Seung Young Kim,Korean College of Helicobacter,Upper Gastrointestinal Research,,
DOI: https://doi.org/10.1111/hel.12592
2019-05-20
Helicobacter
Abstract:<h3> Introduction</h3><p>The eradication rates for <i>Helicobacter pylori</i> have decreased in Korea although the prevalence of this bacterium has also decreased. Antibiotic resistance is likely to be a crucial factor in <i>H. pylori</i> eradication success, and we therefore mapped these resistance patterns nationwide in Korea. </p><h3> Materials and Methods</h3><p>Five hundred and ninety adult subjects were prospectively enrolled from 2017 to 2018 from 15 centers across six geographic areas of Korea. A total of 580 biopsy tissues had been sampled from these patients during an upper endoscopy and were frozen at −80°C and delivered to a central laboratory. The agar dilution method was used to determine the minimum inhibitory concentration of amoxicillin, clarithromycin, metronidazole, tetracycline, ciprofloxacin, and levofloxacin for each <i>H. pylori</i> isolate. </p><h3> Results</h3><p>The culture success rate was 60.2% (349/580). Resistance rates against clarithromycin, metronidazole, amoxicillin, tetracycline, levofloxacin, and ciprofloxacin were 17.8%, 29.5%, 9.5%, 0%, 37.0%, and 37.0%, respectively. The geographic distribution of metronidazole and quinolone resistance was highly variable. Some subjects had multiple <i>H. pylori</i> strains in the antrum and body of the stomach and showed a heterogeneous resistance profile between these anatomic areas. The <i>H. pylori</i> multidrug resistance (MDR) rate was 25.2% (88/349) among amoxicillin, clarithromycin, metronidazole, tetracycline, and quinolone and 11.2% (39/349) among four of these major antibiotics except for quinolone. The Seoul and Chungcheong areas showed a relatively lower MDR rate. </p><h3> Conclusion</h3><p>The antibiotic resistance of <i>H. pylori</i> differs by drug and geographic area in Korea. Detailed nationwide antibiotic resistance mapping is needed to develop an effective <i>H. pylori</i> eradication strategy. </p>
gastroenterology & hepatology,microbiology
What problem does this paper attempt to address?